Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01034852
Other study ID # 09.018
Secondary ID
Status Completed
Phase N/A
First received December 17, 2009
Last updated February 17, 2012
Start date May 2009
Est. completion date January 2011

Study information

Verified date February 2012
Source Cardiopulmonary Research Science and Technology Institute
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

Specific Aims: The primary objective of this registry is to determine the percentage of patients who are free from atrial fibrillation (AF) at 6 and 12 months following a surgical ablation procedure when the patient has a history of failing one or more previous catheter based ablations for AF. The first 3 months following surgical ablation will be a blanking period; any arrhythmia occurring during this time will not be used to determine success.

Primary Objectives:

1. Determine the percent success of surgical ablation for AF at 6, and 12 months both on and off of antiarrhythmic drugs (AAD) following a failed catheter based ablation for AF

2. Record and evaluate all complications associated with the surgical procedure.

Secondary Objectives:

1. Evaluate usage of anticoagulants at 6, and 12 months.

2. Determine the percentage of Pulmonary Veins (PV) that were electrically isolated by intra-operative, pre-surgical mapping


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date January 2011
Est. primary completion date January 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Diagnosis of atrial fibrillation

- Has undergone one or more catheter based ablation procedures for AF and the procedure failed

- Has undergone a minimal access surgical ablation procedure for the treatment of AF following failure of catheter based ablation for AF

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms


Intervention

Procedure:
Totally Thoracoscopic Maze
Epicardial pulmonary vein isolation with additional lesions as determined to be necessary by physician

Locations

Country Name City State
United States Cardiopulmonary Research Science and Technology Institute Dallas Texas
United States Endovascular Research Springfield Oregon

Sponsors (3)

Lead Sponsor Collaborator
Cardiopulmonary Research Science and Technology Institute AtriCure, Inc., Virginia Commonwealth University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Determine the efficacy of surgical ablation for AF at 6, & 12 months both on and off of antiarrhythmic drugs following a failed catheter based ablation for AF. 1 year post operatively Yes
Primary Record and evaluate all complications associated with the surgical procedure. 1 year post operatively Yes
Secondary Evaluate usage of anticoagulants at 6 and 12 months. 1 year post operatively No
Secondary Determine the % of Pulmonary Veins that were electrically isolated by intra-operative, pre-surgical mapping. 1 year post operatively No
See also
  Status Clinical Trial Phase
Completed NCT03148236 - Vitamin C in Atrial Fibrillation Ablation Phase 2
Recruiting NCT06291506 - SUbstrate Ablation in Persistent Atrial Fibrillation for Elimination of Recurrences (SUPAFER). N/A
Completed NCT05086861 - Oesophageal Pacing to Check Left Atrial Posterior Wall Isolation N/A
Recruiting NCT00773539 - A Prospective Randomized Study Comparing Radiofrequency Energy With Cryoenergy Phase 4
Completed NCT01730924 - Comparison of Pulmonary Vein Isolation Using SmartTouch® Catheter With or Without Real-time Contact Force Data N/A